Intra-cytoplasmic Sperm Injection (ICSI)

The micro-injection technique is applied with great success to couples who are facing:
• male infertility (oligospermia, asthenospermia, teratozoospermia, azoospermia)
• low oocyte quality,
• very low number of oocytes

Furthermore, ICSI is indicated for cases where a low contact of oocyte and sperm has been proven. With ICSI, spermatozoa are selected from their morphology and motility, and are transferred one by one into the cytoplasm of the oocyte, using a very fine glass pipette. The objective of the test is to ensure the entry of the sperm into the oocyte. By the ICSI method, very high fertilisation rates are achieved.

Micro-injection has been applied systematically and with great success since 1992. Furthermore, ICSI is appropriate for cases with low fertilisation, proven in previous attempts when conventional IVF has been applied.


• Implementation experience since 1995 exceeding 50,000 cycles in Greece and abroad.
• Supported by methods aiming at the continuous control of embryo culture, to ensure the best possible results.
• Support from special technology (IMSI), which enables magnification of the spermatozoa. This simplifies the selection of spermatozoa without morphological disability. This method greatly improves the paternal influence in the development process of the embryo.
• The results are recorded and are part of the quality control programme to ensure the quality and effectiveness of the method.